title: Microarray analysis reveals the molecular basis of antiarthritic activity of huo-luo-xiao-ling dan.
abstract: Rheumatoid arthritis (RA) is a chronic inflammatory disease of autoimmune origin. Huo-luo-xiao-ling dan (HLXL) is an herbal mixture that has been used in traditional Chinese medicine over several decades to treat chronic inflammatory diseases including RA. However, the mechanism of the anti-arthritic action of this herbal remedy is poorly understood at the molecular level. In this study, we determined by microarray analysis the effects of HLXL on the global gene expression profile of the draining lymph node cells (LNC) in the rat adjuvant arthritis (AA) model of human RA. In LNC restimulated in vitro with the disease-related antigen mycobacterial heat-shock protein 65 (Bhsp65), 84 differentially expressed genes (DEG) (64 upregulated and 20 downregulated) versus 120 DEG (94 upregulated and 26 downregulated) were identified in HLXL-treated versus vehicle (Water)-treated rats, respectively, and 62 DEG (45 upregulated and 17 downregulated) were shared between the two groups. The most affected pathways in response to HLXL treatment included immune response, inflammation, cellular proliferation and apoptosis, and metabolic processes, many of which are directly relevant to arthritis pathogenesis. These results would advance our understanding of the mechanisms underlying the anti-arthritic activity of HLXL.
authors: Department of Microbiology and Immunology, University of Maryland School of Medicine, HSF-1, Suite 380, 685 West Baltimore Street, Baltimore, MD 21201, USA.
authors: Hua
authors: H
authors: Yu
authors: David Y-W
authors: DY
authors: Lee
authors: Siddaraju M
authors: SM
authors: Nanjundaiah
authors: Shivaprasad H
authors: SH
authors: Venkatesha
authors: Brian M
authors: BM
authors: Berman
authors: Kamal D
authors: KD
authors: Moudgil
references: Evid Based Complement Alternat Med. 2012;2012:589256
references: 22474510
references: Semin Immunopathol. 2010 Mar;32(1):43-53
references: 20127485
references: J Interferon Cytokine Res. 2011 Oct;31(10):695-703
references: 21942420
references: Evid Based Complement Alternat Med. 2011;2011:642027
references: 20981317
references: Ann Rheum Dis. 1964 Sep;23:392-6
references: 14206218
references: Front Med. 2011 Jun;5(2):219-28
references: 21695629
references: Best Pract Res Clin Rheumatol. 2008 Apr;22(2):221-38
references: 18455681
references: Ann N Y Acad Sci. 2013 Apr;1283:8-12
references: 23402657
references: Arthritis Res Ther. 2011;13(5):R143
references: 21914168
references: Evid Based Complement Alternat Med. 2012;2012:203043
references: 22536280
references: Arthritis Res Ther. 2006;8(1):R28
references: 16507131
references: Annu Rev Immunol. 2012;30:531-64
references: 22224781
references: J Immunol. 2006 Nov 15;177(10):6634-41
references: 17082575
references: J Ethnopharmacol. 2009 Jan 30;121(3):366-71
references: 19100323
references: PLoS One. 2009 Aug 27;4(8):e6803
references: 19710928
references: Int J Immunopathol Pharmacol. 2012 Apr-Jun;25(2):455-66
references: 22697077
references: J Ethnopharmacol. 2009 May 4;123(1):40-4
references: 19429337
references: Am J Chin Med. 2006;34(5):833-44
references: 17080548
references: J Rheumatol. 2007 Nov;34(11):2134-43
references: 17937454
references: PLoS One. 2009 Oct 22;4(10):e7556
references: 19847310
references: Cell Death Differ. 2003 Jan;10(1):124-33
references: 12655301
references: Int Arch Allergy Appl Immunol. 1963;23:129-39
references: 14057052
references: Zhong Xi Yi Jie He Xue Bao. 2010 May;8(5):438-47
references: 20456842
references: Cell Immunol. 1983 Aug;80(1):198-204
references: 6603276
references: Int Immunopharmacol. 2012 Aug;13(4):499-506
references: 22664142
references: Adv Immunol. 2011;112:137-76
references: 22118408